Evidence map›Paper›PMID 19940913›Full record

ReviewNature2009

Designing materials to direct stem-cell fate.

Matthias P Lutolf, Penney M Gilbert, Helen M Blau

Abstract readReview
In one paragraph

Review in Nature, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 437 papers.

0numbers the graph read from it
0cells of the map it votes in
437citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

437 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Immunomodulatory Delivery Materials for Tissue Repair.Advanced healthcare materials · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Mechanochemistry: Fundamental Principles and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  17. Regenerative therapy · 2025
    Article
  18. Article
  19. Article
  20. Article

377 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthias P LutolfInstitute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland. matthias.lutolf@epfl.ch
Penney M Gilbert
Helen M Blau

Funding

TUMOR BIOLOGYT32CA009151 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1985 to 2014
$5.5M
Stem Cells for Brain and BrawnR01AG020961 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2002 to 2019
$5.0M
ACTIVATORS OF MUSCLE GENESR01AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1990 to 2014
$4.7M
Regulation of Hematopoietic Stem Cell Fate in Bioengineered NichesR01HL096113 · NHLBI · STANFORD UNIVERSITY · PI BLAU, HELEN M · 2009 to 2013
$2.7M
ACTIVATORS OF HUMAN MUSCLE GENESR37AG009521 · NIA · STANFORD UNIVERSITY · PI BLAU, HELEN M · 1995 to 2004
$2.3M
NCI NIH HHS CA09151NCI NIH HHS T32 CA009151NHLBI NIH HHS HL096113NHLBI NIH HHS R01 HL096113NIA NIH HHS AG009521NIA NIH HHS AG020961NIA NIH HHS R01 AG009521NIA NIH HHS R01 AG020961NIA NIH HHS R37 AG009521
6 · The paper itself

Abstract

Proper tissue function and regeneration rely on robust spatial and temporal control of biophysical and biochemical microenvironmental cues through mechanisms that remain poorly understood. Biomaterials are rapidly being developed to display and deliver stem-cell-regulatory signals in a precise and near-physiological fashion, and serve as powerful artificial microenvironments in which to study and instruct stem-cell fate both in culture and in vivo. Further synergism of cell biological and biomaterials technologies promises to have a profound impact on stem-cell biology and provide insights that will advance stem-cell-based clinical approaches to tissue regeneration.

Indexed as

Cell LineageAnimalsBiocompatible MaterialsCell CommunicationHumansRegenerative MedicineStem Cell NicheStem CellsBiocompatible Materials

Identifiers

PMID19940913
PMCPMC2908011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.